Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid).: HP40-352/1-2024E-PDF ; HP40-352/2-2024E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.934797&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Updated guidance on the use of protein subunit COVID-19 vaccine (Novavax Nuvaxovid). |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document |
|
| Note(s) | Cover title. Issued also in French under title: Mise à jour des directives sur l'utilisation du vaccin à sous-unités protéiques contre la COVID-19 (Nuvaxovid de Novavax). At head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Pub.: 230829 (report). Pub.: 230831 (summary). Includes bibliographical references. |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, March 8, 2024. ©2024 |
| Description | 1 online resource (12 pages, 3 unnumbered pages) + 1 summary (4 pages) |
| ISBN | 9780660705675 9780660705682 |
| Catalogue number |
|
| Subject terms | COVID-19 vaccines -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: